Margot Robbie's Wuthering Heights Movie Will Bring The 2026 Box Office To Life

Warner Bros.' adaptation of Wuthering Heights, starring Margot Robbie and Jacob Elordi and directed by Emerald Fennell, is projected by Box Office Theory to open domestically at $45–$60 million over Valentine’s Day weekend (Feb. 13, 2026) against an estimated production spend of roughly $80 million. Early traction from a viral trailer and light direct competition, plus upside from international box office and potential post-opening 'legs,' positions the film to be a meaningful revenue contributor for the studio if it sustains momentum, comparable to recent openings in the $40–50 million range that scaled to strong worldwide totals.

Analysis

Market structure: A strong Wuthering Heights opening (Box Office Theory $45–60M domestic) materially benefits Warner Bros. Discovery (WBD) P&L, theatrical exhibitors (AMC, CNK) and ancillary revenue pools (licensing, international sales). Sony (SONY) gains modestly from family title GOAT ($14.5–20.5M) and recurring franchise annuities; smaller indies/streaming-first titles lose pricing power for theatrical windows if majors sustain hits. International demand is the asymmetric upside — a 2.5x global multiplier (domestic→worldwide) would push revenue into blockbuster territory and meaningfully revise studio quarterly guidance within 1–2 quarters.

Risk assessment: Tail risks include a critical flop, distribution delays, geopolitical/ban issues overseas, or rapid post-theatrical streaming release that compresses box office — each could wipe 20–40% of projected theatrical revenue. Near-term (days–weeks) volatility centers on opening-weekend receipts and reviews; medium-term (months) impacts appear in Q1/Q2 earnings and ad/subscriber metrics; long-term hinges on studio release pacing and streaming window policy changes. Hidden dependency: exhibitor health and pricing elasticity — rising ticket prices or weak weekday holds will shorten legs and reduce backend revenue.

Trade implications: Tactical option plays around release windows are highest-conviction: buy modest WBD call spreads expiring Mar–Apr 2026 to capture upside if opening >$45M, and pair with short modest-sized PAR A (Paramount, PARA) exposure if Scream 7 underperforms. Size positions 1–3% of portfolio; scale up to 3% if opening prints >$50M or global momentum forms by week 2. Use protective puts (10–20% notional) if WBD opening < $30M to limit downside.

Contrarian angles: Consensus assumes theatrical bounce benefits all studios; miss-rate is underappreciated — specialty rom-coms can burn legs quickly despite star power. Historical parallels: prestige rom-coms can have front-loaded domestic runs but weak internationals (see past rom-coms with >$40M openings but <2x global). Unintended consequence: a hit could accelerate M&A chatter around WBD’s content assets, re-rating its multiple regardless of near-term free cash flow; conversely a flop could swiftly depress theater chain equities.

Key Decisions for Investors

• Establish a 2% net long position in WBD ahead of Feb 13 release; hedge by buying a Mar–Apr 2026 call spread (cost-limited) sized to target a 15–30% position-level return if domestic opening ≥ $45M and global multiplier >2.5x; increase to 3% if opening weekend > $50M.
• Initiate a 1–2% long position in SONY using a 4–8 week call spread around GOAT’s Feb release to capture family-audience upside; target +10–15% return if domestic >$18M or better-than-expected Japan/EMEA receipts.
• Put on a pair trade: long WBD (1–2%) vs short PARA (1–2%) because WBD’s early momentum and diversified slate should outperform Paramount if Scream 7/other titles fail to exceed consensus; unwind if any single title posts opening >$60M (reassess on print).
• Risk-manage media exposure: buy protective puts on WBD (cost ~10–20% notional of WBD position) that trigger if opening weekend < $30M or if 10-day Rotten Tomatoes < 55%, limiting downside from a rapid sentiment reversal.